tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Kevin Ellich, 16 are a BUY (38.1%), 22 are a HOLD (52.38%), 4 are a SELL (9.52%).
Analyst Kevin Ellich, currently employed carries an average stock price target met ratio of 100% that have a potential upside of 15.39% achieved within 365 days. Previously, Kevin Ellich worked at CRAIG HALLUM, PIPER SANDLER.
Kevin Ellich’s has documented 106 price targets and ratings displayed on 9 stocks. The coverage was on Healthcare, Financial Services sectors.
Most recent stock forecast was given on AMED, Amedisys at 31-Oct-2019.
Analyst best performing recommendations are on AMED (AMEDISYS).
The best stock recommendation documented was for PETS (PETMED EXPRESS) at 10/17/2019. The price target of $20 was fulfilled within 4 days with a profit of $3.63 (22.17%) receiving and performance score of 55.44.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$101
$9.32 (10.17%)
$101
4 months 1 days ago
(31-Jul-2024)
3/10 (30%)
$2.95 (3.01%)
70
Hold
$101
$9.32 (10.17%)
$101
4 months 7 days ago
(25-Jul-2024)
1/8 (12.5%)
$3.25 (3.32%)
45
Hold
8 months 6 days ago
(26-Mar-2024)
5/10 (50%)
$12.13 (9.49%)
99
Hold
$101
$9.32 (10.17%)
$84
1 years 4 months 1 days ago
(31-Jul-2023)
1/3 (33.33%)
$10.16 (11.18%)
28
Hold
$101
$9.32 (10.17%)
$100
1 years 4 months 5 days ago
(27-Jul-2023)
0/5 (0%)
$10.5 (11.60%)
What Year was the first public recommendation made by Kevin Ellich?
